Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate.

This publication has 14 references indexed in Scilit:

• Perspectives in the treatment of malignant gliomas in adults.
  2002
• Prediction of central nervous system embryonal tumour outcome based on gene expression
  Nature, 2002
• Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents.
  2000
• Phase II Study of Phenylacetate in Patients With Recurrent Malignant Glioma: A North American Brain Tumor Consortium Report
  Journal of Clinical Oncology, 1999
• Phase II Study of Antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in Patients With Recurrent Glioma
  Mayo Clinic Proceedings, 1999
• The New Approaches to Brain Tumor Therapy (NABTT) CNS Consortium: Organization, Objectives, and Activities
  Cancer Control, 1998
• Inhibitory effects of phenylbutyrate on the proliferation, morphology, migration and invasiveness of malignant glioma cells.
  Journal of Neuro-Oncology, 1998
• Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells.
  1997
• Phenylacetate and Phenylbutyrate as Novel, Nontoxic Differentiation Inducers
  Published by Springer Nature ,1997
• Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.
  1994